Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in VanEck Vectors Biotech ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
VanEck Vectors Biotech ETF (BBH) has returned -0.66% so far this year and 20.11% over the past 12 months. Over the last ten years, BBH has returned 6.34% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
VanEck Vectors Biotech ETF
- 1D
- 2.78%
- 1M
- -5.03%
- YTD
- -0.66%
- 6M
- 14.05%
- 1Y
- 20.11%
- 3Y*
- 5.68%
- 5Y*
- 1.70%
- 10Y*
- 6.34%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Nov 23, 1999, BBH's average daily return is +0.05%, while the average monthly return is +0.95%. At this rate, your investment would double in approximately 6.1 years.
Historically, 55% of months were positive and 45% were negative. The best month was Dec 1999 with a return of +38.9%, while the worst month was Apr 2009 at -49.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 6 months.
On a daily basis, BBH closed higher 52% of trading days. The best single day was Oct 13, 2008 with a return of +10.1%, while the worst single day was Apr 1, 2009 at -48.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.90% | 0.68% | -5.03% | -0.66% | |||||||||
| 2025 | 5.27% | -0.41% | -4.41% | -3.01% | -2.79% | 3.33% | 5.71% | 1.94% | 0.31% | 9.33% | 9.19% | -3.83% | 21.18% |
| 2024 | 0.11% | -1.67% | 2.21% | -6.19% | 5.48% | 2.32% | 7.10% | 0.42% | -2.06% | -4.37% | -1.33% | -5.47% | -4.29% |
| 2023 | 5.01% | -6.83% | 3.71% | -1.46% | -3.19% | 0.92% | 3.03% | 1.76% | -4.82% | -7.29% | 5.07% | 9.45% | 3.94% |
| 2022 | -12.91% | -4.75% | 3.23% | -9.71% | 1.10% | -1.49% | 5.84% | -5.40% | -3.56% | 11.68% | 6.95% | -4.57% | -15.25% |
| 2021 | 10.37% | -4.42% | -1.99% | 7.60% | -2.45% | 9.52% | 2.64% | 4.41% | -6.47% | -1.31% | -1.86% | -3.10% | 11.81% |
Benchmark Metrics
VanEck Vectors Biotech ETF has an annualized alpha of 5.56%, beta of 0.86, and R² of 0.33 versus S&P 500 Index. Calculated based on daily prices since November 24, 1999.
- This ETF participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (87.75%) than losses (80.19%) — typical of diversified or defensive assets.
- R² of 0.33 means the benchmark explains less than half of this ETF's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 5.56%
- Beta
- 0.86
- R²
- 0.33
- Upside Capture
- 87.75%
- Downside Capture
- 80.19%
Expense Ratio
BBH has an expense ratio of 0.35%, placing it in the medium range.
Return for Risk
Risk / Return Rank
BBH ranks 50 for risk / return — on par with similar ETFs. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and compare them to a chosen benchmark (S&P 500 Index).
| BBH | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.89 | 0.90 | -0.01 |
Sortino ratioReturn per unit of downside risk | 1.34 | 1.39 | -0.05 |
Omega ratioGain probability vs. loss probability | 1.17 | 1.21 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.75 | 1.40 | +0.36 |
Martin ratioReturn relative to average drawdown | 4.79 | 6.61 | -1.82 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore BBH risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
VanEck Vectors Biotech ETF provided a 0.51% dividend yield over the last twelve months, with an annual payout of $0.96 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.96 | $0.96 | $1.25 | $0.71 | $0.75 | $0.40 | $0.61 | $0.47 | $0.55 | $0.68 | $0.33 | $0.34 |
Dividend yield | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
Monthly Dividends
The table displays the monthly dividend distributions for VanEck Vectors Biotech ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.96 | $0.96 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.25 | $1.25 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.71 | $0.71 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.75 | $0.75 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.40 | $0.40 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the VanEck Vectors Biotech ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the VanEck Vectors Biotech ETF was 72.70%, occurring on Jul 10, 2002. Recovery took 2684 trading sessions.
The current VanEck Vectors Biotech ETF drawdown is 12.76%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -72.7% | Mar 6, 2000 | 588 | Jul 10, 2002 | 2684 | Mar 8, 2013 | 3272 |
| -39.86% | Aug 10, 2021 | 213 | Jun 13, 2022 | — | — | — |
| -33.76% | Jul 21, 2015 | 140 | Feb 8, 2016 | 975 | Dec 20, 2019 | 1115 |
| -22% | Feb 25, 2014 | 34 | Apr 11, 2014 | 94 | Aug 26, 2014 | 128 |
| -20.88% | Feb 24, 2020 | 16 | Mar 16, 2020 | 23 | Apr 17, 2020 | 39 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...